cholesterol-binding protein: Clinical Trials

7 completed, 1 withdrawn. 5 Phase 1, 3 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 1	5	Completed 4, Withdrawn 1
Phase 2	3	Completed 3
Phase 3	2	Completed 2

Follow cholesterol-binding protein: new trials by email Literature Review of cholesterol-binding protein trials Research Report on cholesterol-binding protein

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK) vonapanitase, Placebo - Peripheral Artery Disease	Phase 1	Completed	Proteon Therapeutics	29	2016-11-01	2019-05-02
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) Vonapanitase, Placebo - Chronic Kidney Disease	Phase 3	Completed	Proteon Therapeutics	696	2015-08-01	2019-08-13
A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) PRT-201, Placebo - Chronic Kidney Disease	Phase 3	Completed	Proteon Therapeutics	349	2014-07-01	2019-07-09
Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD) PRT-201 - Peripheral Artery Disease	Phase 1	Completed	Proteon Therapeutics	14	2012-10-01	2015-08-11
A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease PRT-201, Placebo - Chronic Kidney Disease	Phase 2	Completed	Proteon Therapeutics	151	2011-03-01	2015-04-30
A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease PRT-201, Placebo - Chronic Kidney Disease	Phase 1 / Phase 2	Completed	Proteon Therapeutics	89	2009-09-01	2015-04-30
A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients PRT-201 - Chronic Kidney Disease	Phase 1 / Phase 2	Completed	Proteon Therapeutics	66	2008-11-01	2015-04-30
Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries vonapanitase - Peripheral Artery Disease	Phase 1	Withdrawn	Proteon Therapeutics			2019-05-02

Conditions studied

Renal Insufficiency, Chronic (5)  ·  Arteriovenous Fistula (4)  ·  Peripheral Arterial Disease (3)  ·  Constriction, Pathologic (2)  ·  Fistula (2)  ·  Intermittent Claudication (2)  ·  Chronic Limb-Threatening Ischemia (1)

Sponsors

Proteon Therapeutics (8)

Countries

United States (8)  ·  Canada (1)

Top investigators

Christopher D Owens, M.D., M.Sc (1)  ·  Marco Wong, MD, PhD (1)

Results publications

PMID 36567000, PMID 38825327, PMID 23172172, PMID 24684771, PMID 24811601, PMID 30683197, PMID 33482699, PMID 34298589